rs2076604

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 2P and 10B. PP3_ModerateBP6_ModerateBA1

The NM_022089.4(ATP13A2):​c.2251+164A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 152,114 control chromosomes in the GnomAD database, including 4,025 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 4025 hom., cov: 33)

Consequence

ATP13A2
NM_022089.4 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.06

Publications

13 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Illumina
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022089.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 1-16991570-T-C is Benign according to our data. Variant chr1-16991570-T-C is described in ClinVar as Benign. ClinVar VariationId is 1281617.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.549 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022089.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
NM_022089.4
MANE Select
c.2251+164A>G
intron
N/ANP_071372.1Q9NQ11-1
ATP13A2
NM_001141973.3
c.2236+164A>G
intron
N/ANP_001135445.1Q9NQ11-3
ATP13A2
NM_001141974.3
c.2236+164A>G
intron
N/ANP_001135446.1Q9NQ11-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
ENST00000326735.13
TSL:1 MANE Select
c.2251+164A>G
intron
N/AENSP00000327214.8Q9NQ11-1
ATP13A2
ENST00000452699.5
TSL:1
c.2236+164A>G
intron
N/AENSP00000413307.1Q9NQ11-3
ATP13A2
ENST00000341676.9
TSL:1
c.2236+164A>G
intron
N/AENSP00000341115.5Q9NQ11-2

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32188
AN:
151996
Hom.:
4015
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.186
Gnomad EAS
AF:
0.566
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.232
Gnomad NFE
AF:
0.188
Gnomad OTH
AF:
0.228
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.212
AC:
32220
AN:
152114
Hom.:
4025
Cov.:
33
AF XY:
0.222
AC XY:
16512
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.147
AC:
6090
AN:
41502
American (AMR)
AF:
0.305
AC:
4662
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.186
AC:
646
AN:
3470
East Asian (EAS)
AF:
0.566
AC:
2931
AN:
5176
South Asian (SAS)
AF:
0.240
AC:
1158
AN:
4830
European-Finnish (FIN)
AF:
0.311
AC:
3282
AN:
10570
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.188
AC:
12758
AN:
67990
Other (OTH)
AF:
0.227
AC:
480
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1292
2584
3877
5169
6461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.199
Hom.:
12495
Bravo
AF:
0.211
Asia WGS
AF:
0.362
AC:
1256
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Uncertain
23
DANN
Benign
0.53
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.94
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.94
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2076604;
hg19: chr1-17318065;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.